To this end, we recently observed that CIC-DUX4 sarcoma is molecularly dependent on the CCNE/CDK2 complex: CIC-DUX4 acquires neomorphic function as a transcriptional activator to upregulate CCNE1, driving sarcoma growth and survival (4). Here, CDK2 is linked to sarcoma.